Metalyse 40mg Injection
Marketer
Boehringer Ingelheim
Salt Composition
Tenecteplase (40mg)
Overview Metalyse 40mg Injection
Tenecteplase 40mg Injection, a thrombolytic, is a critical treatment for acute myocardial infarction. It dissolves heart vessel clots, restoring blood flow. Administered intravenously by a physician immediately upon initial heart attack symptoms, continuous monitoring of vital signs (including respiration, blood pressure, and oxygen saturation) is essential. Concurrent or subsequent anticoagulant therapy may be employed. Hemorrhage is the most frequent adverse reaction, potentially manifesting as injection site bleeding, epistaxis, hematuria, hematochezia, or gastrointestinal bleeding. Patients should exercise caution with sharp objects (e.g., razors, nail clippers) during therapy. Careful administration by a qualified professional is mandatory; Tenecteplase 40mg Injection is contraindicated in numerous situations, such as recent head trauma, cerebrospinal surgery, or active bleeding. Comprehensive patient history review is crucial prior to administration.
Primary Ingredients of Metalyse 40mg Injection
No text provided to rephrase.
Uses of Metalyse 40mg Injection
Myocardial infarction
Major Benefits of Metalyse 40mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Metalyse 40mg Injection:
- Injection site bleeding
- Nosebleeds
- Blood in stool
- Blood in urine
- Gastrointestinal bleeding
How to use Metalyse 40mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Metalyse 40mg Injection works:
Tenecteplase 40mg Injection is a clot-busting drug that dissolves dangerous blood clots within blood vessels. This action re-establishes blood circulation to compromised tissue, preventing further damage and improving patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Metalyse 40mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Metalyse 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Tenecteplase 40mg injection requires careful consideration during lactation. Nursing should be temporarily discontinued until maternal therapy concludes and the medication is fully cleared from the maternal system.
DrivingNOT RELEVANT
Irrelevant, given that Metalyse 40mg Injection is administered only in inpatient settings.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Metalyse 40mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 40mg Metalyse injections to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Metalyse 40mg Injection :
NA
Facts to Know About Metalyse 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Organic acid-based medications |
| Potential for Dependence | None. |
| Medication Category | HEART |
| Mechanism of Action | Clot-busting drugs: Plasminogen activators |
3,018 People bought this recently